Local Institution - 243

Nagoya 460-0001

0 studies enrolling now · 1 studies all time

What they study most

Myelodysplastic Syndromes

Studies at this site

• A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve — Running, not enrolling